Hanlim Pharmaceutical Co., Ltd.

Kyung-Hee Kim

Won-Seok Lee

Eung-Seok Lee

Jung-Ae Kim

Jun-Woo Kim

Ji-Hoon Lee

Sang-Hyun Min

Ji-Hoon Yu

Ju-Suk Lee

Kyung-Jin Jung

Jae-Young Song

Tae-Cheon Jeong

Jung-Wook Chin

Shin-Ae Kim

Provided is a 2-cyanopyrimidin-4-yl carbamate or urea derivative or pharmaceutically acceptable salt thereof, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The 2-cyanopyrimidin-4-yl carbamate or urea derivative or pharmaceutically acceptable salt thereof selectively inhibits cathepsin K and therefore can be usefully applied for preventing or treating osteoporosis.

2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same

Growing community of inventors

Daegu, South Korea

Kyung-Hee Kim